Literature DB >> 21911899

Takayasu arteritis associated with hepatic sinusoidal dilatation.

Cécile Durant1, Jérome Martin, Baptiste Hervier, Jérome Gournay, Mohamed Hamidou.   

Abstract

Hepatic sinusoidal dilatation (HSD) is pathological entity that is characterized by peliosis hepatis (PH) like lesions, with vascular lesions that consist of multiple cyst-like, blood-filled cavities within the liver. To the best of our knowledge, neither PH nor HSD have been associated with systemic vasculitis. We describe herein two cases of idiopathic HSD associated with Takayasu arteritis (TA), diagnosed at an early stage of vasculitis. The same endothelial target in HSD and TA, and the favorable outcome of HSD with treatment of TA, suggest a pathogenic link between the two diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911899

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  4 in total

1.  Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver.

Authors:  Maxime Ronot; Anne Kerbaol; Pierre-Emmanuel Rautou; Giuseppe Brancatelli; Pierre Bedossa; Dominique Cazals-Hatem; Dominique-Charles Valla; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2015-11-28       Impact factor: 5.315

Review 2.  Peliosis hepatis: Personal experience and literature review.

Authors:  Daniele Crocetti; Andrea Palmieri; Giuseppe Pedullà; Vittorio Pasta; Valerio D'Orazi; Gian Luca Grazi
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

3.  Portal hypertension: an uncommon clinical manifestation of Takayasu arteritis in a 9-year-old child.

Authors:  Cristina N Herrera; Javier E Tomala-Haz
Journal:  Open Access Rheumatol       Date:  2016-11-15

4.  Pathogenesis of liver injury in Takayasu arteritis: advanced understanding leads to new horizons.

Authors:  Kai Kang; Yue Sun; Yi Ling Li; Bing Chang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.